Younes El Yousfi

Younes El Yousfi

Auto-generated profile, based on publicly available information

Younes El Yousfi

Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, CSIC-Universidad de Sevilla-Universidad Pablo de Olavide, 41092 Seville, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2017 in Genes
Verified
Journal Article
Open access
PDF file
MSMarc Suñé-Pou
Marc Suñé-Pou
SPSilvia Prieto-Sánchez
Silvia Prieto-Sánchez
SBSofía Boyero-Corral
Sofía Boyero-Corral
CMCristina Moreno-Castro
Cristina Moreno-Castro
YYYounes El Yousfi
Younes El Yousfi
CSCarlos Suñé
Carlos Suñé
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative splicing (AS) is a key mechanism in the regulation of gene expression. Defects in this regulatory process affect cellular functions and are the cause of many human diseases. Recent advances in our understanding of splicing regulation have led to the development of new tools for manipulating splicing for therapeutic purposes. Several tools, including antisense oligonucleotides and trans-splicing, have been developed to target and alter splicing to correct misregulated gene expression or to modulate transcript isoform levels. At present, deregulated AS is recognized as an important area for therapeutic intervention. Here, we summarize the major hallmarks of the splicing process, the clinical implications that arise from alterations in this process, and the current tools that can be used to deliver, target, and correct deficiencies of this key pre-mRNA processing event.

1 May 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MSMarc Suñé-Pou
Marc Suñé-Pou
SPSilvia Prieto-Sánchez
Silvia Prieto-Sánchez
YYYounes El Yousfi
Younes El Yousfi
SBSofía Boyero-Corral
Sofía Boyero-Corral
Anna Nardi RicartAnna Nardi Ricart
Anna Nardi Ricart
CSCarlos Suñé
Carlos Suñé
Background: Cationic solid lipid nanoparticles (SLNs) have been given considerable attention for therapeutic nucleic acid delivery owing to their advantages over viral and other nanoparticle delivery systems. However, poor delivery efficiency and complex formulations hinder the clinical translation of SLNs.
Aim:
The aim of this study was to formulate and characterize SLNs incorporating the cholesterol derivative cholesteryl oleate to produce SLN–nucleic acid complexes with reduced cytotoxicity and more efficient cellular uptake. Methods: Five cholesteryl oleate-containing formulations were prepared. Laser diffraction and laser Doppler microelectrophoresis were used to evaluate particle size and zeta potential, respectively. Nanoparticle morphology was analyzed using electron microscopy. Cytotoxicity and cellular uptake of lipoplexes were evaluated using flow cytometry and fluorescence microscopy. The gene inhibition capacity of the lipoplexes was assessed using siRNAs to block constitutive luciferase expression. Results: We obtained nanoparticles with a mean diameter of approximately 150–200 nm in size and zeta potential values of 25–40 mV. SLN formulations with intermediate concentrations of cholesteryl oleate exhibited good stability and spherical structures with no aggregation. No cell toxicity of any reference SLN was observed. Finally, cellular uptake experiments with DNA- and RNA-SLNs were performed to select one reference with superior transient transfection efficiency that significantly decreased gene activity upon siRNA complexation. Conclusion: The results indicate that cholesteryl oleate-loaded SLNs are a safe and effective platform for nonviral nucleic acid delivery.


4 February 2025 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
YYY. El Yousfi
Y. El Yousfi
FFF. J. Fernández-Farrán
F. J. Fernández-Farrán
JOJavier Oliver
Javier Oliver
ALAbelardo Lopez-Rivas
Abelardo Lopez-Rivas
RYRosario Yerbes
Rosario Yerbes
In tumors, cancer cells are frequently exposed to adverse environmental conditions that result in endoplasmic reticulum (ER) stress. Mechanical signals emerging from extracellular matrix (ECM) rigidity and cell shape regulate the activity of transcriptional co-activators Yes-associated protein (YAP) and its paralog Transcriptional Coactivator with PDZ-binding motif (TAZ). However, the role of ECM rigidity and YAP/TAZ in tumor cell fate decisions under ER stress remains relatively unexplored. Our results suggest that the YAP/TAZ system plays an important role in the control of ER stress-induced cell death by mechanical signaling arising from ECM stiffness in tumor cells. Mechanistically, YAP/TAZ regulates apoptosis induced by ER stress in tumor cells by controlling the activation of the TRAIL-R2/DR5-mediated extrinsic apoptotic pathway through a dual mechanism. On the one hand, the YAP/TAZ system prevents intracellular TRAIL-R2/DR5 clustering in tumor cells. On the other hand, it inhibits cFLIP down-regulation in tumor cells experiencing ER stress. In addition, YAP/TAZ controls the expression of pro-inflammatory interleukin-8 (IL-8/CXCL8) in tumor cells undergoing ER stress by a TRAIL-R2/DR5/caspase-8-dependent mechanism. Although other mechanisms may also be involved in controlling cell death and inflammation in tumor cells facing environmental stress, our results support a model in which regulation of the subcellular localization and activity of the YAP/TAZ transcriptional co-activators could contribute to the microenvironmental control of cell fate decisions in tumor cells undergoing ER stress.

1 August 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MSMarc Suñé-Pou
Marc Suñé-Pou
MLMaría J. Limeres
María J. Limeres
INIsaac Nofrerias
Isaac Nofrerias
ANAnna Nardi-Ricart
Anna Nardi-Ricart
SPSilvia Prieto-Sánchez
Silvia Prieto-Sánchez
JSJosep Mª Suñé-Negre
Josep Mª Suñé-Negre

1 October 2017 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
NSNoemí Sánchez-Hernández
Noemí Sánchez-Hernández
SPSilvia Prieto-Sánchez
Silvia Prieto-Sánchez
CMCristina Moreno-Castro
Cristina Moreno-Castro
JMJuan Pablo Muñoz-Cobo
Juan Pablo Muñoz-Cobo
YYYounes El Yousfi
Younes El Yousfi
CSCarlos Suñé
Carlos Suñé